期刊
MOVEMENT DISORDERS
卷 26, 期 -, 页码 S17-S26出版社
WILEY
DOI: 10.1002/mds.23481
关键词
DBS; dystonia
资金
- Eutherapie
- Allergan
- Merz
- Ipsen
- Boehringer
- Dystonia Study Group
- NIH
- Cambridge Press
- Walters-Kluver
- CurePSP
- St. Jude Medical
- Canadian Institute of Health Research
Background: The preoperative evaluation in dystonia aims at characterizing the severity and topography of motor symptoms in patients, who have previously been selected for deep brain stimulation (DBS). Methods: The literature search was performed using PubMed, CINAHL, and the Cochrane Collaborative databases. Results: Commonly used scales for clinical assessment are the Burke-Fahn-Marsden dystonia rating scale for generalized dystonia and the Toronto Western Spasmodic Torticollis Scale for cervical dystonia. Motor assessment is completed by quality of life and functional scales, such as the Short-Form Health Survey (SF-36) or the Parkinson's Disease Questionnaire 39. Validated rating scales for cranial or upper limb dystonia are lacking. Discussion: In common clinical practice, these outcome measures can be administered in an open-label fashion because double blind assessment is only required for ascertaining new treatment indications or research purposes. The same measures are to be used postoperatively to revaluate outcome after DBS. Brain MRI is required to confirm diagnosis and assess structural abnormalities. Other imaging techniques, particularly functional imaging, are used for research purposes. (C) 2011 Movement Disorder Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据